Feb 28, 2025 07:00AM
Mar 5, 2024 07:00AM
Dec 9, 2022 04:05PM
Dec 9, 2022 04:05PM
Dec 7, 2022 08:45AM
Dec 7, 2022 08:45AM
Dec 7, 2022 08:45AM ADMA Biologics Announces Pricing of Public Offering for $60 Million of Common Stock
Dec 6, 2022 04:05PM
Dec 6, 2022 04:05PM
Nov 11, 2021 05:29AM
Oct 26, 2021 07:20AM
Oct 25, 2021 04:01PM
Oct 25, 2021 04:01PM
Oct 21, 2021 09:01AM ADMA Biologics (ADMA) Announces Proposed $50M Stock Offering at $1/sh
Oct 21, 2021 09:00AM
Oct 21, 2021 09:00AM
Oct 20, 2021 04:02PM
Oct 20, 2021 04:01PM
Oct 20, 2021 04:01PM
Jun 14, 2021 07:00AM
Jun 14, 2021 07:00AM ADMA Biologics to Participate in the Raymond James Human Health Innovation Virtual Conference
Feb 22, 2021 08:00AM
Feb 22, 2021 08:00AM
Aug 24, 2020 09:31AM
May 29, 2019 07:11AM
May 29, 2019 07:11AM
May 21, 2019 04:20PM
May 21, 2019 04:20PM ADMA Biologics Announces Closing of $51.75 Million Public Offering and Full Exercise of Underwriters’ Option to Purchase Additional Shares
May 17, 2019 07:13AM
May 17, 2019 07:11AM
May 17, 2019 07:11AM
Feb 25, 2019 07:38AM
Feb 25, 2019 07:38AM
Jun 12, 2018 04:05PM
Jun 12, 2018 04:05PM ADMA Biologics Announces Closing of $40M Public Offering
Jun 8, 2018 09:09AM
Jun 8, 2018 09:08AM
Jun 8, 2018 09:08AM
Jun 7, 2018 04:05PM
Jun 7, 2018 04:05PM
Jun 7, 2018 04:05PM
Feb 27, 2018 07:08AM ADMA Biologics to Present at Raymond James’ 39th Annual Institutional Investors Conference
Feb 27, 2018 07:08AM
Nov 14, 2017 09:21AM
Nov 14, 2017 07:54AM
Nov 13, 2017 12:30PM
Nov 9, 2017 09:00AM
Nov 9, 2017 08:58AM
Aug 1, 2016 06:40AM Raymond James Downgrades ADMA Biologics (ADMA) to Market Perform
May 3, 2016 10:47AM

32,346 total articles have been posted to this entity.

Click Here to Sign-Up for StreetInsider.com Premium to View All